During the past decade, Ospedale Santa Maria Annunziata conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Santa Maria Annunziata" #1 sponsor was "Azienda Ospedaliera Universitaria Integrata Verona" with 2 trials, followed by "Fondazione Melanoma Onlus" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Gruppo di Ricerca GISSI" with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Santa Maria Annunziata" #1 collaborator was "Agenzia Italiana del Farmaco" with 3 trials as a collaborator, "Azienda Sanitaria-Universitaria Integrata di Udine" with 2 trials as a collaborator, "Clinical Research Technology S.r.l." with 1 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator and "University of Campania "Luigi Vanvitelli"" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Santa Maria Annunziata" are "COVID-19" (2 trials), "Acute Respiratory Failure" (1 trials), "Atrial Arrhythmia" (1 trials), "Atrial Fibrillation" (1 trials) and "Bifascicular Block" (1 trials). Many other conditions were trialed in "Ospedale Santa Maria Annunziata" in a lesser frequency.

Most popular intervention types in "Ospedale Santa Maria Annunziata" are "Drug" (10 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "RBV" (2 trials), "SOF" (2 trials), "Sotrovimab" (2 trials) and "Atezolizumab 1200 MG in 20 ML Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Santa Maria Annunziata" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Santa Maria Annunziata". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Ospedale Santa Maria Annunziata, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Santa Maria Annunziata, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".